Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
Introduction: Schizophrenia is a lifelong condition associated with several comorbid conditions such as physical illnesses like obesity, as well as co-occurring psychiatric symptoms such as depression. Research regarding susceptibility to some of these comorbidities has primary focused on genetic ri...
Main Authors: | Pooja Kumar, A. Zarina Kraal, Andreas M. Prawdzik, Allison E. Ringold, Vicki Ellingrod |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2020.620097/full |
Similar Items
-
Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia
by: Savushkina Olga K., et al.
Published: (2020-01-01) -
Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
by: Thomas L Schwartz, et al.
Published: (2012-11-01) -
Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia
by: Caroline Madeira, et al.
Published: (2018-12-01) -
Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics
by: Kristen M. Ward, et al.
Published: (2021-05-01) -
Magnetic resonance imaging in studying schizophrenia, negative symptoms and the glutamate system
by: Oliver eGruber, et al.
Published: (2014-04-01)